ERK2/p38α MAPK-IN-1 is a potent and selective ERK2 and p38α MAPK inhibitor. ERK2/p38α MAPK-IN-1 binds to the allosteric site of ERK2 and p38α MAPK in distinct manners, and it can be used for the research of type 2 diabetes.
Usually ships within 24 hours.